Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

• Sponsor: Pfizer (Industry)
• Overall Status: Completed
• CT.gov ID: NCT00401232
• Collaborator: (none)
• Enrollment: 955
• Locations: 2
• Arm: 1
• Actual Duration (Months): 136
• Patients Per Site: 477.5
• Patients Per Site Per Month: 3.5

Study Details

Study Description

Brief Summary

This is a study to collect blood from volunteers to assist in assay development.

Condition or Disease	Intervention/Treatment	Phase
Healthy Subjects	Procedure: Blood Collection	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 955 participants
• Allocation: Non-Randomized
• Intervention Model: Single Group Assignment
• Primary Purpose: Diagnostic
• Official Title: Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
• Actual Study Start Date: Aug 1, 2006
• Actual Primary Completion Date: Dec 1, 2017
• Actual Study Completion Date: Dec 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Other: Arm 1	Procedure: Blood Collection; Blood Collection

Outcome Measures

Primary Outcome Measures

1. "No outcome measures". Blood collected for assay development. [1 hour]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 64 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Healthy Volunteers aged 18-64

Exclusion Criteria:

• Bleeding disorder

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	SNBL Clinical Pharmacology Center	Baltimore	Maryland	United States	21201
2	Frontage Clinical Services Inc	Hackensack	New Jersey	United States	07601

Sponsors and Collaborators

• Pfizer

Investigators

• Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• To obtain contact information for a study center near you, click here.

Publications

None provided.

• Responsible Party: Pfizer
• ClinicalTrials.gov Identifier: NCT00401232
• Other Study ID Numbers: 6108A1-800; B1971032
• First Posted: Nov 20, 2006
• Last Update Posted: Mar 19, 2018
• Last Verified: Mar 1, 2018

Study Results

No Results Posted as of Mar 19, 2018